These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6422149)

  • 1. Diagnosis of Tay-Sachs disease using radiolabelled chondroitin 6-sulphate-derived trisaccharides.
    Yutaka T; Kato T; Okada S; Midorikawa M; Yabuuchi H
    J Inherit Metab Dis; 1983; 6(3):135-6. PubMed ID: 6422149
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired degradation of chondroitin sulfate in GM2-gangliosidosis.
    Yutaka T; Kato T; Okada S; Yabuuci H
    Clin Genet; 1982 Oct; 22(4):165-71. PubMed ID: 6217929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Tay-Sachs disease by estimation of beta-N-acetylhexosaminidase activity using a radiolabeled hyaluronic acid-derived trisaccharide substrate.
    Yutaka T; Kato T; Midorikawa M; Doke M; Okada S; Yabuuchi H
    Clin Chim Acta; 1984 Feb; 137(2):159-68. PubMed ID: 6231138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential degradation of a chondroitin sulphate trisaccharide by lysosomal enzymes from embryonic-chick epiphysial cartilage.
    Ingmar B; Wasteson A
    Biochem J; 1979 Apr; 179(1):7-13. PubMed ID: 475761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of penultimate N-acetylgalactosamine 4-sulfate on chondroitin chain elongation.
    Cogburn JN; Silbert JE
    Carbohydr Res; 1986 Aug; 151():207-12. PubMed ID: 3094936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of [3H]chondroitin 4-sulphate and re-utilization of the [3H]hexosamine component by the isolated perfused rat liver.
    MacNicholl AD; Wusteman FS; Winterburn PJ; Powell GM; Curtis CG
    Biochem J; 1980 Jan; 186(1):279-86. PubMed ID: 6768355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity and appearance of isoenzyme spectrums of some lysosomal hydrolases in biopsy material of human chorion].
    Beĭer EM; Vidershaĭn GIa; Bakharev VA; Rozovskiĭ IS
    Vopr Med Khim; 1983; 29(2):130-3. PubMed ID: 6222539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphation heterogeneity in the trisaccharide (GalNAcSbeta1, 4GlcAbeta1,3GalNAcS) isolated from the non-reducing terminal of human aggrecan chondroitin sulphate.
    West LA; Roughley P; Nelson FR; Plaas AH
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):223-9. PubMed ID: 10432320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of oligosaccharides from the chondroitin/dermatan sulfates. 1H-NMR and 13C-NMR studies of reduced trisaccharides and hexasaccharides.
    Huckerby TN; Nieduszynski IA; Giannopoulos M; Weeks SD; Sadler IH; Lauder RM
    FEBS J; 2005 Dec; 272(24):6276-86. PubMed ID: 16336265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic synthesis of alpha-L-fucosyl-N-acetyllactosamines and 3'-O-alpha-L-fucosyllactose utilizing alpha-L-fucosidases.
    Murata T; Morimoto S; Zeng X; Watanabe S; Usui T
    Carbohydr Res; 1999 Aug; 320(3-4):192-9. PubMed ID: 10573857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical Issues with Genetic Testing for Tay-Sachs.
    Clayton T
    J Christ Nurs; 2017; 34(4):246-249. PubMed ID: 28902054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A; Holding J; Carey WF
    Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of chondroitin 4-sulphate by tri-fluoroacetolysis: isolation of oligosaccharides from the carbohydrate-protein linkage region.
    Gunnarsson A; Svensson S; Rodén L
    Carbohydr Res; 1984 Oct; 133(1):75-82. PubMed ID: 6437677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondroitinase ABC-resistant sulfated trisaccharides isolated from digests of chondroitin/dermatan sulfate chains.
    Sugahara K; Takemura Y; Sugiura M; Kohno Y; Yoshida K; Takeda K; Khoo KH; Morris HR; Dell A
    Carbohydr Res; 1994 Mar; 255():165-82. PubMed ID: 8181005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosyl transferases in chondroitin sulphate biosynthesis. Effect of acceptor structure on activity.
    Gundlach MW; Conrad HE
    Biochem J; 1985 Mar; 226(3):705-14. PubMed ID: 3921015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of hyaluronate and chondroitin sulphate to liver endothelial cells.
    Laurent TC; Fraser JR; Pertoft H; Smedsrød B
    Biochem J; 1986 Mar; 234(3):653-8. PubMed ID: 3087347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of Tay-Sachs disease in cell-free amniotic fluid.
    Christomanou H; Cáp C; Sandhoff K
    Klin Wochenschr; 1978 Nov; 56(22):1133-5. PubMed ID: 713433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation of vascular surfaces: differential saturation with glycosaminoglycans and their quantitative analysis.
    Hale G; Hann AC; Wusteman FS; Gacesa P
    Biomaterials; 1988 Jul; 9(4):376-8. PubMed ID: 3145779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The liver in lipid storage disease: biochemical basis of pathogenesis and clinical features.
    Brady RO; James SP; Barranger JA
    Prog Liver Dis; 1982; 7():331-46. PubMed ID: 6810410
    [No Abstract]   [Full Text] [Related]  

  • 20. Determinants of utilization of Tay-Sachs screening.
    Garber AP; Platt LD; Wang SJ; Jam K; Carlson DE; Rotter JI
    Obstet Gynecol; 1993 Sep; 82(3):460-3. PubMed ID: 8355954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.